UNSPSC 51124304: Quinidine gluconate

This classification denotes a cation channel blocker and antimalarial agent with the molecular formula C20H24N2O2.C6H12O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R6875N380F, chemically known as quinidine, d-gluconate (salt) but more generally known as quinidine gluconate, which bears US NIH Compound Identifier 64642. European Medicines Agency schedules Quinidine gluconate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04170MIG.

UNSPSC 51124304 Quinidine gluconate is a Commodity code capturing pharmaceutical supplies for emergency medical services, specifically advanced life support medications procured by fire rescue and EMS departments. State and local governments buy individual doses of cardiac and vasopressor medications—epinephrine, adenosine, diltiazem, labetalol, and quinidine gluconate among them—in vial or injection form for use in ambulances, fire stations, and emergency response vehicles. Issuing bodies under this code include municipal fire departments and county EMS systems; the recent activity shows municipal purchasing offices handling procurement for their fire rescue operations. Vendors must meet strict pharmaceutical compliance requirements, including expiration-date warranties (typically nine months or more from acceptance), OSHA Safety Data Sheet documentation, accessibility conformance to WCAG 2.2 and Section 508 standards, and often rapid delivery windows (ten calendar days or less). Small Local Business Enterprise set-asides and bid discounts appear in municipal solicitations.

The City of Tampa's Purchasing Department solicited Advanced Life Support Medications (IFB 26P00188, due April 8, 2026) for Tampa Fire Rescue in Hillsborough County, Florida, requesting 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials at an estimated contract value of $40,000.00. The contract term was one year with two optional one-year renewals and up to three additional 30-day unilateral extensions. Florida appears to be the jurisdiction with recent documented activity under this code, though the sparse recent-opportunities record suggests limited visibility into state and local quinidine gluconate procurement or significant purchasing consolidation under higher-level pharmaceutical family codes.